SavedAdd your journal

Journals / Turkish Journal of Hematology / 2019 / Cilt: 36 - Sayı: 1

Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives

Bendamustin ve Rituksimab Tedavisi, Kronik Lenfositik Lösemi, Direkt Antiglobulin Test ve Yanlış Negatiflik

Won SRIWIJITALAI
Viroj WIWANITKIT
Pages
53–54
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

SRIWIJITALAI, W., WIWANITKIT, V. (2022). Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives. Turkish Journal of Hematology, Cilt: 36 - Sayı: 1, 53–54. https://ajindex.com/articles/606698

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Eren R, Suyanı E. Early direct antiglobulin test negativity after bendamustine and rituximab treatment in chronic lymphocytic leukemia: two cases. Turk J Hematol 2018;35:312-313
  2. Hubinont PO. The prozone phenomenon in haemagglutination reactions; with special reference to the quantitative antiglobulin test. Br Med J 1951;2:708-711
  3. Salama A, Mueller-Eckhardt C. Elimination of the prozone effect in the antiglobulin reaction by a simple modification. Vox Sang 1982;42:157- 159
  4. Ceppellini R. Causes of error in interpretation of direct Coombs’ test; false negative reaction due to prozone and false positive reaction due to cold autoantibodies. Sangue 1951;24:158-159.